New antibody-combination therapy boosts human lymphoma cure rate in mouse models
Thursday, September 2, 2010 - 13:42
in Health & Medicine
(PhysOrg.com) -- More than half of laboratory mice with human non-Hodgkin's lymphoma are cured by a treatment involving just two monoclonal antibodies, according to a new study.